Direct Flow Medical TAVR System, DISCOVER post-market study, real-world results, TCT 2015

Image courtesy of Direct Flow Medical Inc.

News | Heart Valve Repair | October 22, 2015
October 22, 2015 — Direct Flow Medical Inc. announced one-year outcomes from the DISCOVER post-market study that...
PulsePoint Respond app, new CPR guidelines, sudden cardiac arrest, social media
Feature | Mobile Devices | October 21, 2015
October 21, 2015 — For the first time, cardiopulmonary resuscitation (CPR) guidelines issued by the American Heart...
Lumason, CMS, ultrasound contrast agent, approval for reimbursement, Bracco
News | Contrast Media | October 21, 2015
October 21, 2015 — Bracco Diagnostics Inc. announced that Lumason was approved by the Centers for Medicare and Medicaid...
thrombus aspiration, STEMI patients, TCT 2015, TOTAL study
Feature | Thrombectomy Devices | October 20, 2015
October 20, 2015 — A pair of studies presented at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT)...
BRAVO 3 trial results, bivalirudin, heparin, anticoagulation, TAVR, TCT 2015
Feature | Antiplatelet and Anticoagulation Therapies | October 20, 2015
October 20, 2015 — Results from the BRAVO 3 trial found that...
VIVA 15 conference, late-breaking clinical trials, VIVA Physicians
News | Peripheral Arterial Disease (PAD) | October 19, 2015
October 19, 2015 — Vascular Interventional Advances (VIVA) Physicians, a not-for-profit organization dedicated to...
Praxbind, Pradaxa reversal agent, FDA approval, emergency situations
Technology | Antiplatelet and Anticoagulation Therapies | October 19, 2015
October 19, 2015 — The U.S. Food and Drug Administration (FDA) granted accelerated approval to Praxbind (idarucizumab)...
Amaranth Fortitute Bioresorbable stent

The Amaranth Fortitute bioresorbable stent was among several fully bioresorbing platforms discussed in sessions, late breaking trial data presentations and on the expo floor at TCT 2015.

Feature | TCT | October 19, 2015 | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline
There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT)...
transradial access, TRI, DRAGON trial, TCT 2015, non-inferiority, transfemoral access, TFO
Feature | Radial Access | October 18, 2015
October 18, 2015 — Results from a prospective randomized trial of...
FFR-CT, cost and quality of life outcomes, TCT 2015, PLATFORM trial

Image courtesy of HeartFlow Inc.

Feature | CT Angiography (CTA) | October 18, 2015
October 18, 2015 — New results from a multicenter, prospective study show that assessing...
IN.PACT SFA study, TCT 2015, drug-coated balloons, PTA, SFA disease, superficial femoral artery

Image courtesy of Medtronic

Feature | Peripheral Arterial Disease (PAD) | October 18, 2015
October 18, 2015 — Two-year results from the IN.PACT SFA study found the use of a...
cardiac MRI, heart age, left ventricular change, Multi-Ethnic Study of Atherosclerosis
News | Cardiac Imaging | October 16, 2015
October 16, 2015 – The main pumping chamber of the heart ages differently in men and women, according to a new...
RESPECT trial, long-term study results, TCT 2015, PFO closure, recurrent cryptogenic stroke

Image courtesy of GE Healthcare

Feature | Stroke | October 16, 2015
October 16, 2015 — Long-term study results from the RESPECT trial found that closing a patent foramen ovale (PFO) with...
Amaranth Medical Bioresorbable Scaffold, Fortitude stent
News | Stents Bioresorbable | October 16, 2015
October 16, 2015 — Enrollment has successfully concluded in its multi-center, international CE mark clinical trials...
Claret embolic protection, TAVR, cerebral protection

The Claret TAVR embolic protection system as seen in the aortic arch under angiography. The loops contain embolic filters they protect the ostium of vessles leading to the brain.

Feature | Heart Valve Repair | October 16, 2015
October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at...
Overlay Init